E3 ubiquitin-protein ligase RNF43
E3 ubiquitin-protein ligase RNF43 (721-729) is a synthetic peptide fragment derived from the C-terminal region of the RNF43 protein, a key component in the regulation of the Wnt signaling pathway through its role as an E3 ubiquitin ligase. As a defined peptide sequence, it serves as a valuable biochemical tool for probing the structural and functional aspects of RNF43, particularly in the context of post-translational modification and cellular signaling. Its unique sequence enables researchers to investigate peptide-mediated interactions, ubiquitination processes, and the broader regulatory mechanisms in which RNF43 participates. The availability of this peptide supports advanced studies in molecular biology, protein chemistry, and signal transduction research.
Peptide functional studies: The RNF43 (721-729) peptide is widely used to elucidate the molecular interactions governing E3 ubiquitin ligase activity. Researchers employ this fragment to map the binding interfaces and recognition motifs involved in substrate specificity or interaction with regulatory proteins. By providing a defined segment of the RNF43 protein, the peptide enables detailed investigation into how specific amino acid residues contribute to the recruitment of ubiquitination targets or modulate ligase function, thereby advancing understanding of protein turnover and signaling fidelity.
Epitope mapping and antibody validation: As a synthetic representation of a distinct RNF43 region, the 721-729 peptide serves as a critical reagent for epitope mapping studies. Laboratories utilize it to characterize antibody specificity, assess cross-reactivity, and validate immunochemical reagents directed against RNF43. These applications are essential for developing reliable immunodetection assays, including Western blotting, ELISA, and immunoprecipitation protocols, which underpin the study of RNF43 expression, localization, and regulatory dynamics in cellular systems.
Substrate competition assays: The peptide is employed as a competitive substrate or inhibitor in biochemical assays designed to dissect the ubiquitination cascade. By introducing the RNF43 (721-729) fragment into in vitro systems, researchers can monitor its ability to compete with full-length protein substrates for binding to E2 conjugating enzymes or other pathway components. Such experiments provide mechanistic insights into the determinants of substrate selection and the modulation of ubiquitin transfer, facilitating the development of targeted strategies for pathway manipulation.
Protein-protein interaction analysis: The defined sequence of the RNF43 (721-729) peptide makes it an excellent probe for studying protein-protein interactions relevant to the Wnt signaling pathway. It can be incorporated into surface plasmon resonance, pull-down, or co-immunoprecipitation assays to identify and characterize binding partners of RNF43 or to explore the molecular basis of regulatory interactions. These studies contribute to a deeper understanding of the network connectivity and dynamic regulation inherent to signal transduction cascades.
Peptide-based assay development: The RNF43 (721-729) peptide is also utilized in the design and optimization of high-throughput screening assays aimed at identifying modulators of E3 ligase activity. Its defined structure and functional relevance allow for the establishment of robust biochemical or biophysical assays, which are instrumental for screening compound libraries, evaluating enzymatic kinetics, or assessing the impact of mutations. Such applications support both basic research and early-stage drug discovery efforts targeting ubiquitin-mediated regulatory pathways.
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More